JM Tolmann Laboratories

What JM Tolmann Laboratories does

JM Tolmann Laboratories is a Philippine pharmaceutical company founded in 1994 and headquartered at 95 North Zuzuarregui Street, Holy Spirit, Diliman, Quezon City. The firm manufactures, markets, and distributes branded medicines, positioning itself as the leading local manufacturer of Vitamin C and B-Complex products in the Philippines and operating under the tagline "Gamot gawang Pilipino para sa Pilipino" (medicine made by Filipinos for Filipinos). Its disclosed product portfolio spans two categories: drug pharmaceuticals (including the antibiotic Cefixime and Betahistine, used for vestibular disorders) and food supplements (CalciFirst, Vitalungs, Calciumate, EZGrow).

Since a 2006 restructuring, the business has operated through two independent divisions. The Marketing Division handles direct distribution of branded medicines to major clients across the Philippines, while the Manufacturing Division focuses on toll manufacturing and a Product Development Program aimed at building a larger clientele of partner brands. Revenue is generated from sales of self-manufactured branded medicines to Filipino consumers and from contract/toll manufacturing fees on behalf of client brands producing food supplements and drug pharmaceuticals. Pricing is not publicly disclosed, and the customer base consists of Filipino consumers seeking affordable access to quality medicines, with the company explicitly targeting financial barriers as the primary pain point addressed.

The firm is privately held, employs 51-100 people, has no subsidiaries, no disclosed funding rounds, and operates exclusively in the Philippines with no global footprint claim. Sustained Philippine Department of Health (DOH) recognition plaques in 2003, 2008, and 2011, alongside Pharmaceutical and Chemical Industry (PCPI) Regular Membership from 2006 and Plaques of Appreciation in 2008 and 2013, provide the primary markers of regulatory standing and industry credibility. No management team, ownership structure, or AI/technology stack is disclosed in the source material.

Name

JM Tolmann Laboratories

Legal name

JM Tolmann Laboratories

Website

https://jmtolmannlab.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

JM Tolmann Laboratories is a Philippine pharmaceutical company founded in 1994 that manufactures, markets, and distributes affordable branded medicines, food supplements, and toll-manufactured drug pharmaceuticals to Filipino consumers and partner brands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Branded generics
• Toll manufacturing
• Food supplements
• Vitamin manufacturing

Headquarters

HQ city

Quezon City

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Branded Medicine Manufacturing and Distribution: JM Tolmann Laboratories generates revenue through the manufacture, marketing, and distribution of quality branded medicines. The company operates its own marketing division to distribute products to major clients, and also operates a toll manufacturing division that produces medicines and food supplements for client brands.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

JM Tolmann Laboratories manufactures, markets, and distributes branded pharmaceutical products and food supplements in the Philippines. Its Manufacturing Division produces drug pharmaceuticals (including antibiotics such as Cefixime and Betahistine) and food supplements (CalciFirst, Vitalungs, Calciumate, EZGrow), while also providing toll manufacturing and new product development services to client brands. Its Marketing Division handles distribution of these branded medicines to major clients and healthcare providers nationwide.

Product overview

JM Tolmann Laboratories is a Philippine pharmaceutical company established in 1994 that manufactures, markets, and distributes quality branded medicines. The company operates two main divisions: the Marketing Division (operating independently since 2006) and the Manufacturing Division focused on toll manufacturing and new product development. Their product portfolio consists of two categories: Drug Pharmaceuticals (including antibiotics like Cefixime and Betahistine) and Food Supplements (including CalciFirst, Vitalungs, Calciumate, and EZGrow). The company positions itself as a provider of affordable medicines for the Filipino people, with a focus on Vitamin C and B-Complex products as leading offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Cefixime Antibiotic drug pharmaceutical product manufactured by JM Tolmann Laboratories as part of its branded generic drug portfolio, distributed through the Marketing Division to major clients and healthcare providers in the Philippines.
• Betahistine Drug pharmaceutical product manufactured by JM Tolmann Laboratories (commonly used for vestibular disorders), part of its branded drug portfolio distributed in the Philippines.
• CalciFirst Calcium-based food supplement manufactured by JM Tolmann Laboratories as part of its branded food supplement portfolio for Filipino consumers.
• Vitalungs Food supplement product manufactured by JM Tolmann Laboratories as part of its branded food supplement portfolio targeting Filipino consumers.
• Calciumate Calcium-based food supplement manufactured by JM Tolmann Laboratories as part of its branded food supplement portfolio for the Filipino market.
• EZGrow Food supplement product manufactured by JM Tolmann Laboratories as part of its branded food supplement portfolio for Filipino consumers.
• Toll Manufacturing Services for Drug Pharmaceuticals and Food Supplements Contract / toll manufacturing service operated by JM Tolmann Laboratories' Manufacturing Division, producing drug pharmaceuticals and food supplements for client brands. Includes a Product Development Program aimed at building a larger clientele network of partners while maintaining quality and affordable medicines.

Quantifiable outcome

• Established as a leading national pharmaceutical company since 1994

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights2 records

Direct peers

• Amherst Laboratories: Philippine pharmaceutical company manufacturing a range of generic drug formulations and health supplements. Directly comparable as a mid-sized local manufacturer serving the same end markets.
• Hizon Laboratories: Philippine contract and branded pharmaceutical manufacturer offering toll manufacturing services and own-brand products. Highly comparable to JM Tolmann's dual business model of branded distribution plus contract manufacturing.
• Lloyd Laboratories: Philippine pharmaceutical manufacturer producing generic and branded pharmaceutical products. Similar positioning as a locally manufactured, affordability-focused pharma company in the Philippine market.
• Natrapharm: Philippine pharmaceutical manufacturer focused on generic medicines and healthcare products. Comparable in scale and product mix to JM Tolmann, competing in the same domestic pharmacy and drugstore channels.
• Pascual Laboratories: Philippine pharmaceutical manufacturer producing branded generics, vitamins, and food supplements — directly comparable product categories to JM Tolmann. Similar local manufacturer positioning and distribution through Philippine pharmacy chains.

Broad incumbents

• Recipharm: European-headquartered CDMO offering contract manufacturing of oral solid dose and other pharmaceutical forms. Comparable to JM Tolmann's manufacturing services business as an established global contract manufacturer.
• Catalent: Global contract development and manufacturing organization (CDMO) with fill-finish and softgel capabilities. Relevant peer to JM Tolmann's toll manufacturing division, though at vastly larger scale and geographic footprint.
• United Laboratories (Unilab): The largest Philippine pharmaceutical manufacturer, producing branded generics, consumer health products, and prescription drugs. Direct competitor to JM Tolmann in the local branded generic and vitamin/supplement segments, with vastly greater scale, distribution, and marketing reach.

Emerging players

• Piramal Pharma Solutions: Global contract manufacturer of finished dosage forms with operations in multiple geographies. Comparable as a contract manufacturing peer, though with significantly broader capabilities and international reach than JM Tolmann.
• Sydenham Laboratories: Philippine-based pharmaceutical manufacturer producing generic and branded formulations for the domestic market. Closely comparable in size, geography, and product portfolio mix to JM Tolmann.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Jmtolmannlab
• LinkedInlinkedin.com/company/jm-tolmann-lab

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JM Tolmann Laboratories